The FDA Just Approved America's First DNA-Injection Immunotherapy, and Inovio's Stock Tripled in a Day
The FDA granted accelerated approval to Inovio's Voceryq on Oct 30, 2026 — its first-ever product and the first plasmid DNA immunotherapy approved in the US.























